IFN-γ is primarily released by antigen-recognized and activated T cells (31), which triggers B7-H1 gene expression in lung cancer cells, cholangiocarcinoma cells, head and neck cancers, as well as HCC through the JAK/STAT1 pathway (31–34). This evidence concerns the gene IFNG and lung cancer.